SPARC preserves endothelial glycocalyx integrity, and protects against adverse cardiac inflammation and injury during viral myocarditis

Marieke Rienks*, Paolo Carai, Jurgen van Teeffelen, Bart Eskens, Wouter Verhesen, Bianca Hemmeryckx, Daniel M. Johnson, Rick van Leeuwen, Elizabeth A. Jones, Stephane Heymans, Anna-Pia Papageorgiou

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Web of Science)

Abstract

Myocardial damage as a consequence of cardiotropic viruses leads to a broad variety of clinical presentations and is still a complicated condition to diagnose and treat. Whereas the extracellular matrix protein Secreted Protein Acidic and Rich in Cysteine or SPARC has been implicated in hypertensive and ischemic heart disease by modulating collagen production and cross-linking, its role in cardiac inflammation and endothelial function is yet unknown.

Absence of SPARC in mice resulted in increased cardiac inflammation and mortality, and reduced cardiac systolic function upon coxsackievirus-B3 induced myocarditis. Intra-vital microscopic imaging of the microvasculature of the cremaster muscle combined with electron microscopic imaging of the microvasculature of the cardiac muscle uncovered the significance of SPARC in maintaining endothelial glycocalyx integrity and subsequent barrier properties to stop inflammation. Moreover, systemic administration of recombinant SPARC restored the endothelial glycocalyx and consequently reversed the increase in inflammation and mortality observed in SPARC KO mice in response to viral exposure. Reducing the glycocalyx in vivo by systemic administration of hyaluronidase, an enzyme that degrades the endothelial glycocalyx, mimicked the barrier defects found in SPARC KO mice, which could be restored by subsequent administration of recombinant SPARC.

In conclusion, the secreted glycoprotein SPARC protects against adverse cardiac inflammation and mortality by improving the glycocalyx function and resulting endothelial barrier function during viral myocarditis. (C) 2018 The Authors. Published by Elsevier B.V.

Original languageEnglish
Pages (from-to)21-34
Number of pages14
JournalMatrix Biology
Volume74
DOIs
Publication statusPublished - Dec 2018

Keywords

  • SPARC
  • Endothelial glycocalyx
  • Viral myocarditis
  • Extracellular matrix
  • Inflammation
  • FIBRILLAR COLLAGEN CONTENT
  • DIASTOLIC FUNCTION ROLE
  • PHENOTYPIC HETEROGENEITY
  • EXTRACELLULAR-MATRIX
  • PRESSURE-OVERLOAD
  • HEPARAN-SULFATE
  • AGE
  • ANGIOGENESIS
  • ACTIVATION
  • FIBROSIS

Cite this